![Sylke Hassel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sylke Hassel
Amministratore Delegato presso PharmaZell GmbH
Provenienza dei contatti di primo grado di Sylke Hassel
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
PharmaZell GmbH
![]() PharmaZell GmbH BiotechnologyHealth Technology PharmaZell GmbH engages in the development and provision of pharmaceutical active ingredients. It also offers services for formulation development and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Its products include manufactured amino acids and controlled substances. The company was founded in 1946 and is headquartered in Raubling, Germany.
3
| Subsidiary | Biotechnology | 3 |
Zellbios GmbH
![]() Zellbios GmbH Pharmaceuticals: MajorHealth Technology Part of PharmaZell GmbH, Zellbios GmbH is a German company that specializes in manufacturing cdmo solutions, supplying specialty api products, and producing anticancer drugs. Zellbios is based in Raubling, DE, and Sylke Hassel has been the CEO of the company since 2022. The company offers a wide range of reliable services for small molecule apis and biopharmaceuticals to innovators. Zellbios also supports innovative agrochemical companies with their apis for fungicides, insecticides, and herbicides in a safe and sustainable way. The company provides cdmo services for highly potent apis and cytotoxics and is an expert in pre-formulated nitroglycerin production.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sylke Hassel tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
ZOOPLUS SE | Specialty Stores | Director/Board Member | |
Maxburg Capital Partners GmbH
![]() Maxburg Capital Partners GmbH Investment ManagersFinance Maxburg Capital Partners GmbH (Maxburg Capital Partners) is a private equity firm founded in 2014 by Moritz Greve and Florian Seubert. The firm headquartered in Munich, Germany. | Investment Managers | Founder | |
INSEAD | College/University | Masters Business Admin | |
ESCP Europe | College/University | Graduate Degree | |
Farmabios SpA
![]() Farmabios SpA Pharmaceuticals: MajorHealth Technology Farmabios SpA engages in the manufacture and marketing of active ingredients for pharmaceutical applications. It offers oral cephalosporins, steroids hormones, highly potent substances, multipurpose plant for steroids, sterile cephalosporins, sterile steroids, and antineoplastics. The company was founded in 1961 and is headquartered in Gropello Cairoli, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Algae-C, Inc.
![]() Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Biotechnology | Director/Board Member | |
Axplora
![]() Axplora Pharmaceuticals: OtherHealth Technology Axplora is a German company that focuses on delivering sustainable and technologically advanced API products and services. The private company is based in Raubling, Germany. The company's goal is to benefit people, patients, and the planet. The CEO of the company is Sylke Hassel. | Pharmaceuticals: Other | Chief Operating Officer |
Statistiche
Distribuzione geografica
Germania | 6 |
Francia | 2 |
Italia | 2 |
Canada | 2 |
Settori
Consumer Services | 4 |
Health Technology | 4 |
Retail Trade | 2 |
Finance | 2 |
Posizioni
Director/Board Member | 3 |
Chief Operating Officer | 3 |
Compliance Officer | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
Moritz Greve | 5 |
Pere Paton | 3 |
Kurt Mayrhofer | 2 |
Mario di Giacomo | 2 |
- Borsa valori
- Insiders
- Sylke Hassel
- Connessioni Società